New Drug Stops Weight Gain and Lowers Cholesterol by Targeting Nitric Oxide

The Surprising Point Where Video Gaming Stops Being Harmless

New Drug Slashes Dangerous Blood Fats by Nearly 40% in First Human Trial

Study of 15,000 people with depression: 1 in 5 experience ‘atypical’ type characterised by excessive sleep and weight gain, poorer response to common antidepressants (SSRIs), and generic risk for metabolic, inflammatory, and circadian (body clock) disturbances